Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 15.34%22.03B | 21.62%14.34B | 23.63%7B | 19.10%26.83B | 18.04%19.1B | 13.67%11.79B | 11.74%5.66B | 2.87%22.53B | 2.68%16.18B | 4.12%10.37B |
| Operating income | 15.34%22.03B | 21.62%14.34B | 23.63%7B | 19.10%26.83B | 18.04%19.1B | 13.67%11.79B | 11.74%5.66B | 2.87%22.53B | 2.68%16.18B | 4.12%10.37B |
| Cost of sales | -6.73%-13.99B | -9.25%-9.13B | -9.98%-4.46B | -5.69%-18.06B | -5.76%-13.11B | -3.87%-8.35B | -2.36%-4.06B | 5.34%-17.09B | 5.78%-12.4B | 4.46%-8.04B |
| Operating expenses | -6.73%-13.99B | -9.25%-9.13B | -9.98%-4.46B | -5.69%-18.06B | -5.76%-13.11B | -3.87%-8.35B | -2.36%-4.06B | 5.34%-17.09B | 5.78%-12.4B | 4.46%-8.04B |
| Gross profit | 34.20%8.03B | 51.66%5.21B | 58.16%2.54B | 61.23%8.77B | 58.27%5.99B | 47.48%3.44B | 45.42%1.61B | 41.37%5.44B | 45.47%3.78B | 50.85%2.33B |
| Selling expenses | -3.19%-3.27B | -12.87%-2.22B | -25.88%-1.17B | -12.40%-4.4B | -13.42%-3.17B | -9.13%-1.96B | -5.33%-927.06M | 20.42%-3.92B | 23.64%-2.79B | 25.87%-1.8B |
| Administrative expenses | -0.57%-1.53B | -0.53%-1.03B | 3.03%-515.64M | 4.30%-2.03B | 5.30%-1.53B | 8.24%-1.02B | 6.98%-531.78M | 15.81%-2.12B | 5.50%-1.61B | 4.27%-1.11B |
| Research and development expenses | 5.55%-2.61B | 8.17%-1.71B | 12.81%-841.48M | 17.51%-3.69B | 11.92%-2.77B | 10.33%-1.86B | 6.00%-965.12M | 6.25%-4.47B | 4.02%-3.14B | 3.11%-2.07B |
| Operating profit | 142.20%620.57M | 118.99%266.62M | 101.83%15.01M | 73.46%-1.34B | 60.89%-1.47B | 47.08%-1.4B | 40.45%-818.6M | 39.41%-5.06B | 37.66%-3.76B | 36.58%-2.65B |
| Financing income | -2.00%318.34M | -16.16%195.81M | -29.30%94.17M | -19.82%434.98M | -21.92%324.83M | -21.71%233.55M | -8.93%133.21M | 93.02%542.47M | 140.83%416.02M | 230.46%298.3M |
| Financing cost | -59.25%-110.21M | -32.49%-68.08M | -3.16%-32.57M | 45.92%-89.19M | 49.02%-69.21M | 51.38%-51.38M | 45.28%-31.57M | 34.27%-164.93M | 27.55%-135.75M | 14.51%-105.68M |
| Special items of earning before tax | 48.76%-128.5M | 4.50%-148.8M | -64.18%-75.7M | -767.04%-402.01M | -763.81%-250.81M | -146.16%-155.81M | -106.70%-46.11M | -105.02%-46.37M | -68.10%37.78M | 1,583.17%337.54M |
| Earning before tax | 147.78%700.19M | 117.83%245.55M | 100.12%911K | 70.42%-1.4B | 57.41%-1.47B | 35.10%-1.38B | -27.62%-763.07M | 36.07%-4.73B | 41.94%-3.44B | 49.92%-2.12B |
| Tax | -278.20%-23.19M | -926.33%-37.95M | -641.87%-11.59M | 146.43%36.54M | 117.69%13.01M | 108.26%4.59M | 95.08%-1.56M | 24.43%-78.71M | 12.09%-73.57M | 1.79%-55.59M |
| After-tax profit from continuing operations | 146.61%677.01M | 115.12%207.61M | 98.60%-10.68M | 71.66%-1.36B | 58.67%-1.45B | 36.96%-1.37B | -21.44%-764.63M | 35.91%-4.81B | 41.52%-3.52B | 49.29%-2.18B |
| Earning after tax | 146.61%677.01M | 115.12%207.61M | 98.60%-10.68M | 71.66%-1.36B | 58.67%-1.45B | 36.96%-1.37B | -21.44%-764.63M | 35.91%-4.81B | 41.52%-3.52B | 49.29%-2.18B |
| Minority profit | 80.27%-3.12M | 85.23%-2.29M | 90.21%-1.58M | -258.85%-16.85M | -246.34%-15.83M | -359.07%-15.54M | -721.13%-16.09M | 199.70%10.61M | 230.95%10.81M | 40.30%-3.38M |
| Profit attributable to shareholders | 147.34%680.13M | 115.47%209.9M | 98.78%-9.1M | 72.07%-1.35B | 59.25%-1.44B | 37.58%-1.36B | -19.25%-748.55M | 35.68%-4.82B | 41.26%-3.53B | 49.30%-2.17B |
| Basic earnings per share | 146.96%1.62 | 115.34%0.5 | 98.89%-0.02 | 72.32%-3.23 | 59.60%-3.45 | 38.26%-3.26 | -17.65%-1.8 | 38.55%-11.67 | 43.89%-8.54 | 51.47%-5.28 |
| Diluted earnings per share | 145.80%1.58 | 115.03%0.49 | 98.89%-0.02 | 72.32%-3.23 | 59.60%-3.45 | 38.26%-3.26 | -17.65%-1.8 | 38.55%-11.67 | 43.89%-8.54 | 51.47%-5.28 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PwC Accounting Firm | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.